PURPOSE: Concerns exist regarding breast cancer patients' access to breast reconstruction, which provides important psychosocial benefits. PATIENTS AND METHODS: Using the MarketScan database, a claims-based data set of US patients with employment-based insurance, we identified 20,560 women undergoing mastectomy for breast cancer from 1998 to 2007. We evaluated time trends using the Cochran-Armitage test and correlated reconstruction use with plastic-surgery workforce density and other treatments using multivariable regression. RESULTS: Median age of our sample was 51 years. Reconstruction use increased from 46% in 1998 to 63% in 2007 (P < .001), with increased use of implants and decreased use of autologous techniques over time (P < .001). Receipt of bilateral mastectomy also increased: from 3% in 1998 to 18% in 2007 (P < .001). Patients receiving bilateral mastectomy were more likely to receive reconstruction (odds ratio [OR], 2.3; P < .001) and patients receiving radiation were less likely to receive reconstruction (OR, 0.44; P < .001). Rates of reconstruction receipt varied dramatically by geographic region, with associations with plastic surgeon density in each state and county-level income. Autologous techniques were more often used in patients who received both reconstruction and radiation (OR, 1.8; P < .001) and less frequently used in patients with capitated insurance (OR, 0.7; P < .001), patients undergoing bilateral mastectomy (OR, 0.5; P < .001), or patients in the highest income quartile (OR, 0.7; P = .006). Delayed reconstruction was performed in 21% of patients who underwent reconstruction. CONCLUSION: Breast reconstruction has increased over time, but it has wide geographic variability. Receipt of other treatments correlates with the use of and approaches toward reconstruction. Further research and interventions are needed to ensure equitable access to this important component of multidisciplinary treatment of breast cancer.
PURPOSE: Concerns exist regarding breast cancerpatients' access to breast reconstruction, which provides important psychosocial benefits. PATIENTS AND METHODS: Using the MarketScan database, a claims-based data set of US patients with employment-based insurance, we identified 20,560 women undergoing mastectomy for breast cancer from 1998 to 2007. We evaluated time trends using the Cochran-Armitage test and correlated reconstruction use with plastic-surgery workforce density and other treatments using multivariable regression. RESULTS: Median age of our sample was 51 years. Reconstruction use increased from 46% in 1998 to 63% in 2007 (P < .001), with increased use of implants and decreased use of autologous techniques over time (P < .001). Receipt of bilateral mastectomy also increased: from 3% in 1998 to 18% in 2007 (P < .001). Patients receiving bilateral mastectomy were more likely to receive reconstruction (odds ratio [OR], 2.3; P < .001) and patients receiving radiation were less likely to receive reconstruction (OR, 0.44; P < .001). Rates of reconstruction receipt varied dramatically by geographic region, with associations with plastic surgeon density in each state and county-level income. Autologous techniques were more often used in patients who received both reconstruction and radiation (OR, 1.8; P < .001) and less frequently used in patients with capitated insurance (OR, 0.7; P < .001), patients undergoing bilateral mastectomy (OR, 0.5; P < .001), or patients in the highest income quartile (OR, 0.7; P = .006). Delayed reconstruction was performed in 21% of patients who underwent reconstruction. CONCLUSION: Breast reconstruction has increased over time, but it has wide geographic variability. Receipt of other treatments correlates with the use of and approaches toward reconstruction. Further research and interventions are needed to ensure equitable access to this important component of multidisciplinary treatment of breast cancer.
Authors: Amy K Alderman; Sarah T Hawley; Monica Morrow; Barbara Salem; Ann Hamilton; John J Graff; Steven Katz Journal: Ann Surg Oncol Date: 2011-01-05 Impact factor: 5.344
Authors: Claudia R Albornoz; Peter B Bach; Babak J Mehrara; Joseph J Disa; Andrea L Pusic; Colleen M McCarthy; Peter G Cordeiro; Evan Matros Journal: Plast Reconstr Surg Date: 2013-01 Impact factor: 4.730
Authors: M Overgaard; M B Jensen; J Overgaard; P S Hansen; C Rose; M Andersson; C Kamby; M Kjaer; C C Gadeberg; B B Rasmussen; M Blichert-Toft; H T Mouridsen Journal: Lancet Date: 1999-05-15 Impact factor: 79.321
Authors: M Overgaard; P S Hansen; J Overgaard; C Rose; M Andersson; F Bach; M Kjaer; C C Gadeberg; H T Mouridsen; M B Jensen; K Zedeler Journal: N Engl J Med Date: 1997-10-02 Impact factor: 91.245
Authors: Ashish K Chawla; Lisa A Kachnic; Alphonse G Taghian; Andrzej Niemierko; Daniel T Zapton; Simon N Powell Journal: Int J Radiat Oncol Biol Phys Date: 2002-10-01 Impact factor: 7.038
Authors: Natalie B Jones; John Wilson; Linda Kotur; Julie Stephens; William B Farrar; Doreen M Agnese Journal: Ann Surg Oncol Date: 2009-06-09 Impact factor: 5.344
Authors: Reshma Jagsi; Jing Jiang; Adeyiza O Momoh; Amy Alderman; Sharon H Giordano; Thomas A Buchholz; Lori J Pierce; Steven J Kronowitz; Benjamin D Smith Journal: Ann Surg Date: 2016-02 Impact factor: 12.969
Authors: Jessica Billig; Reshma Jagsi; Ji Qi; Jennifer B Hamill; Hyungjin M Kim; Andrea L Pusic; Edward Buchel; Edwin G Wilkins; Adeyiza O Momoh Journal: Plast Reconstr Surg Date: 2017-06 Impact factor: 4.730
Authors: Jada G Hamilton; Margaux C Genoff; Melissa Salerno; Kimberly Amoroso; Sherry R Boyar; Margaret Sheehan; Megan Harlan Fleischut; Beth Siegel; Angela G Arnold; Erin E Salo-Mullen; Jennifer L Hay; Kenneth Offit; Mark E Robson Journal: Breast Cancer Res Treat Date: 2017-02-01 Impact factor: 4.872
Authors: Emily W Gower; Lisa J Keay; Dianne E Stare; Pallavi Arora; Sandra D Cassard; Ashley Behrens; James M Tielsch; Oliver D Schein Journal: Ophthalmology Date: 2015-06-02 Impact factor: 12.079
Authors: Reshma Jagsi; Adeyiza O Momoh; Ji Qi; Jennifer B Hamill; Jessica Billig; Hyungjin M Kim; Andrea L Pusic; Edwin G Wilkins Journal: J Natl Cancer Inst Date: 2018-02-01 Impact factor: 13.506
Authors: Jennica Platt; Toni Zhong; Rahim Moineddin; Gillian L Booth; Alexandra M Easson; Kimberly Fernandes; Peter Gozdyra; Nancy N Baxter Journal: World J Surg Date: 2015-08 Impact factor: 3.352
Authors: Shailesh Agarwal; Kelley M Kidwell; Aaron Farberg; Jeffrey H Kozlow; Kevin C Chung; Adeyiza O Momoh Journal: Ann Surg Oncol Date: 2015-01-07 Impact factor: 5.344
Authors: Ronnie L Shammas; Yi Ren; Samantha M Thomas; Scott T Hollenbeck; Rachel A Greenup; Rachel C Blitzblau Journal: Plast Reconstr Surg Date: 2019-09 Impact factor: 4.730
Authors: Michelle C Roughton; Paul DiEgidio; Lei Zhou; Karyn Stitzenberg; Anne Marie Meyer Journal: Plast Reconstr Surg Date: 2016-08 Impact factor: 4.730